The agency overseeing Medicare and Medicaid proposes $4.5 billion of spending cuts for home healthcare, and new economies on ...

There's a strong case that healthcare is the most important sector in the stock market. Investors stand to benefit as ...

The rapid adoption of the Omnipod 5 answered a question automated insulin delivery system manufacturers posed for years: with clear health benefits and payer coverage, why has pump adoption been so ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

Hybrid closed-loop insulin delivery systems are transforming the management of type 1 diabetes. Young children with type 1 ...

The evolution of diabetes technologies has led to the expansion of automated insulin delivery for type 2 diabetes, continuous ...

FN Media Group News Commentary - The global diabetic retinopathy market has shown a consistent growth in recent years and is expected to continue for the coming several years. According to a ...

ACTON, Mass., June 10, 2025--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible ...

Made by Boston-based Insulet, the Omnipod 5 is a tubeless patch pump that provides 3 days of nonstop insulin management. Children and adults can use the Omnipod for both type 1 and type 2 diabetes.

Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Omnipod 5 is now commercially available in ...